SCHEMBL754958

SCHEMBL754958

CCOc1cc(C=O)ccc1OC

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 11/20 0.72
TSHR P16473 1/20 0.72
FDPS P14324 1/20 0.67
MAPT P10636 2/20 0.61
NPSR1 Q6W5P4 2/20 0.61
SMN1; SMN2 Q16637 2/20 0.61
LMNA P02545 1/20 0.61
HTT P42858 1/20 0.61
TACR2 P21452 1/20 0.60
HPGD P15428 3/20 0.56
TDP1 Q9NUW8 3/20 0.56
AOX1 Q06278 1/20 0.56
TRIM24 O15164 1/20 0.56
ALDH5A1 P51649 1/20 0.56
ABAT P80404 1/20 0.56
TRIM33 Q9UPN9 1/20 0.56
L3MBTL1 Q9Y468 2/20 0.56
AMY1A P0DUB6 1/20 0.55
KDM4E B2RXH2 1/20 0.55
PDCD1 Q15116 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30416638 1.00 ALDH1A1 (0.72) ALDH1A1TSHRFDPSMAPTNPSR1
SCHEMBL356800 0.93 FDPS (0.77) ALDH1A1TSHRFDPSMAPTNPSR1
SCHEMBL27518165 0.92 FDPS (0.66) ALDH1A1TSHRFDPSMAPTNPSR1
SCHEMBL493684 0.91 ALDH1A1 (0.73) ALDH1A1TSHRFDPSMAPTNPSR1
SCHEMBL30159697 0.91 ALDH1A1 (0.73) ALDH1A1TSHRFDPSMAPTNPSR1
SCHEMBL9174838 0.90 FDPS (0.73) ALDH1A1TSHRFDPSMAPTNPSR1
SCHEMBL703866 0.88 ALDH1A1 (0.62) ALDH1A1TSHRFDPSMAPTNPSR1
SCHEMBL7661907 0.87 FDPS (0.86) ALDH1A1TSHRFDPSMAPTNPSR1
SCHEMBL1121628 0.86 FDPS (0.73) ALDH1A1TSHRFDPSMAPTNPSR1
SCHEMBL5974454 0.86 FDPS (0.77) ALDH1A1TSHRFDPSMAPTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 593 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120091758-A Arthropod control composition 弗门尼舍有限公司 2025-06-03 CN claimed
US-20250113823-A1 Arthropod Control Compositions FIRMENICH SA (CH) 2025-04-10 US claimed
US-12234384-B2 Adhesion-improving composition for textile material and associated reinforcing textile material PORCHER INDUSTRIES (FR) 2025-02-25 US claimed
EP-4444095-A1 ARTHROPOD CONTROL COMPOSITIONS Firmenich SA (CH) 2024-10-16 EP claimed
CN-118684604-A Preparation method of intermediate impurity and finished product impurity of apremilast 江苏正大清江制药有限公司 2024-09-24 CN claimed
CN-118591291-A Arthropod control composition 弗门尼舍有限公司 2024-09-03 CN claimed
WO-2024084006-A1 ARTHROPOD CONTROL COMPOSITIONS FIRMENICH SA (CH) 2024-04-25 WO claimed
CN-113896674-B Synthesis method of apremilast 深圳华中科技大学研究院 2023-10-27 CN claimed
WO-2023139053-A1 ARTHROPOD CONTROL COMPOSITIONS FIRMENICH SA (CH) 2023-07-27 WO claimed
CN-112578038-B Analysis and detection method for berberine hydrochloride bulk drug 沈阳化工大学 2022-09-30 CN claimed
WO-2002083123-A1 AURONES AS TELOMERASE INHIBITORS PHARMACIA ITALIA SPA (IT) 2002-10-24 WO claimed
EP-0674232-B1 Recording sheets XEROX CORP (US) 2000-05-31 EP claimed
EP-0709361-B1 Process for the preparation of isovanilline RHODIA CHIMIE SA (FR) 1999-02-03 EP claimed
US-5786516-A Process for the preparation of isovanillin RHONE-POULENC CHIMIE (FR) 1998-07-28 US claimed
US-5663022-A Recording sheets XEROX CORPORATION (US) 1997-09-02 US claimed
US-5648552-A Process for the preparation of isovanillin RHONE-POULENC CHIMIE (FR) 1997-07-15 US claimed
EP-0709361-A1 Process for the preparation of isovanilline RHONE-POULENC CHIMIE (FR) 1996-05-01 EP claimed
EP-0674232-A2 Recording sheets XEROX CORPORATION (US) 1995-09-27 EP claimed
EP-0031253-B1 PROCESS FOR PREPARING 3,4-SUBSTITUTED BENZALDEHYDES SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1983-10-05 EP claimed
EP-0031253-A1 Process for preparing 3,4-substituted benzaldehydes SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1981-07-01 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250113823-A1 Arthropod Control Compositions AGO2, EXOSC9, C5 ALDH1A1 3700/4885TSHR 4582/4885FDPS 1436/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.